Expand the Network

With $161.3 million over the next five years, NIH plans to expand the Pharmacogenomics Research Network, the agency reports. The network had been working on linking genetic variants to cancer, heart disease, asthma, and among others and now will also include research into rheumatoid arthritis and bipolar disorder. The new awards include 14 research grants, with projects ranging from pharmacogenomics in rural areas ranging to the pharmacogenomics of mood stabilizers, as well as seven resource awards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.